{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-085220","form_type":"8-K","ticker":"SRTS","cik":"0001494891","company_name":"Sensus Healthcare, Inc.","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.242508+00:00","generated_at":"2026-06-08T06:34:35.176611+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sensus Healthcare Q3 revenues down 57% YoY to $3.9M; net loss of $1.5M","bullets":["Revenues $3.9M vs $9.0M Q3 2022; net loss $1.5M ($0.09/sh) vs net income $1.8M ($0.11) prior year.","Adjusted EBITDA negative $1.7M vs positive $2.3M a year ago.","Shipped 11 SRT units (3 outside US, 5 to one large customer); cash $20.5M, no debt.","Board approved $3.0M stock repurchase program.","Submitted 510(k) for aesthetic drug delivery system; expects completion by end of 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-085220","json":"https://secwatch.observer/filing/0001213900-23-085220.json","markdown":"https://secwatch.observer/filing/0001213900-23-085220.md","text":"https://secwatch.observer/filing/0001213900-23-085220.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1494891/000121390023085220/0001213900-23-085220-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1494891/000121390023085220/ea187860-8k_sensus.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T06:34:35.176611+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"51581c5a30684a7d377794b0841555b9a4c973f0","claim":"Sensus Healthcare, Inc. reported the third quarter of 2023 results: revenue $3.9 million, net income Net loss was $1.5 million, EPS $(0.09) per share.","evidence_excerpt":"Sensus Healthcare Reports Third Quarter 2023 Financial Results Revenues of $3.9 million reflect seasonality and macroeconomic conditions","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1494891/000121390023085220/0001213900-23-085220-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter of 2023"},{"label":"Revenue","value":"$3.9 million"},{"label":"Net income","value":"Net loss was $1.5 million"},{"label":"EPS","value":"$(0.09) per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}